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Introduction
Complementary and alternative medicine (CAM) has been defined 
as “diagnosis, treatment and/or prevention which complements main-
stream medicine by contributing to a common whole, satisfying a de-
mand not met by orthodoxy, or diversifying the conceptual framework 
of medicine” [1].
Many cancer patients seem to experience both physical (e.g. more 
energy, less pain or nausea) as well as psychological (e.g. less anxiety 
or depression) benefits from using CAM [2,3]. Thus, many cancer pa-
tients try at least, one type of CAM [4]. Reliable prevalence data do, 
however, not exist. 
The aim of this systematic review was to summarize and critically 
evaluate surveys monitoring the prevalence of CAM use by UK cancer 
patients during the past decade. 
Method
Systematic literature searches were performed for all English lan-
guage references using AMED, CINAHL, COCHRANE, EMBASE and 
MEDLINE for surveys published between 01 January 2000 and 07 Oc-
tober 2011. Details of the search strategy are presented in the appen-
dix. Additionally, relevant book chapters, review articles and our own 
departmental files were hand-searched for further relevant articles. 
Surveys which examined the prevalence of CAM use by UK cancer pa-
tients providing quantitative prevalence data were included. Surveys 
reporting only qualitative data were excluded. Information from the 
included surveys were extracted according to pre-defined criteria and 
assessed descriptively by two independent reviewers. Disagreements 
were settled through discussion. 
Acupuncture/acupressure, Alexander Technique, aromatherapy, 
autogenic training, Ayurveda, (Bach) flower remedies, biofeedback, 
chelation therapy, chiropractic, Feldenkrais, herbal medicine, home-
opathy, hypnotherapy, imagery, kinesiology, massage (any type), med-
itation, naturopathy, neural therapy, osteopathy, qi gong, reflexology, 
relaxation therapy, shiatsu, spiritual healing, static magnets, tai chi, and 
yoga were all considered as CAM. Non-herbal dietary supplements and 
vitamins, psychotherapy, physical exercises or some physiotherapeutic 
modalities such as electrotherapy or ultrasound were not considered to 
be CAM and therefore were excluded from analyses.
The top 5 CAM modalities (1=most popular) from each survey 
were ranked and averaged across the surveys to generate an overall 
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Background: Cancer patients seem to frequently use Complementary and Alternative Medicine (CAM). 
However, estimates of the level of usage vary widely. This systematic review is aimed at determining the prevalence 
of CAM-use in cancer patients of the United Kingdom (UK). 
Method: Five databases were searched for English language peer-reviewed surveys published between 01 
January 2000 and 07 October 2011. In addition, relevant book chapters and our own departmental files were hand-
searched. 
Results: 25 surveys were included with a total sample size of 6798. Across all studies, the median prevalence 
rate of CAM-use was 30.5 (standard deviation=10.3). Herbal medicine was the most popular CAM modality, followed 
by homeopathy, aromatherapy, reflexology and relaxation. Conclusions: Many UK cancer patients use CAM. 
Oncologists need to be aware of these numbers as they can impact daily practice on the management of cancer 
patients.
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Figure 1: Flow Diagram.
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ranking. Then the total number of surveys in which a particular CAM 
modality was the most prevalent/popular one was provided and the 
median of those figures was calculated. Where available, we calculated 
the average of the % of responders who stated they experienced benefit 
or were satisfied with CAM as well as those who reported adverse ef-
fects after using CAM and their cost for purchasing CAM. 
Results 
The searches generated 15935 articles, of which 15910 were ex-
cluded (see flow chart diagram (Figure 1)). Twenty five surveys met 
our eligibility criteria [2,5-28]. Detailed characteristics of the included 
surveys relating to CAM in general are presented in Supplimentary 
table. Table 1 represents the included surveys on specific CAM modali-
ties. Fourteen surveys originated from England, 1 from England and 
Scotland, 1 from Scotland, 1 from Wales. The remaining 8 surveys per-
tained either to the whole of the UK, or their geographical location was 
not clearly specified.
 The total number of patients included in the 25 surveys was 6798. 
Twenty two surveys were on CAM in general while three were specifi-
cally on herbal medicines. Across surveys on CAM in general, the me-
dian prevalence rate since the diagnosis of cancer was 30.5 (SD=10.3). 
The use of a random sampling method was mentioned in 2 (8%) sur-
veys [10,17]. The median response rate was 71.0 (SD=14.3). Perceived 
effectiveness of CAM was mentioned in 16 (64%) surveys [2,7,9,10,13-
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Table 1: Main findings for specific CAM modalities.
Citation: Posadzki P, Watson LK, Alotaibi A ,Ernst E (2012) Prevalence of Complementary and Alternative Medicine-use by UK Cancer Patients: A 
Systematic Review of Surveys. J Integr Oncol 1:102. doi:10.4172/2329-6771.1000102
Page 3 of 5
J Integr Oncol
ISSN: 2329-6771   JIO, an open access journal Volume 1 • Issue 1 • 1000102
18,20,21,25-28]. The median perceived effectiveness across all surveys 
was 42.5 (SD=20.2). Adverse effects were reported in 7 (28%) surveys 
[10,14,15,17,18,22,28] and the median incidence rate across all surveys 
was 2.5 (SD=4.6). The costs of CAM were mentioned in 11 (44%) sur-
veys [8,9,13-20,25]. Based on 6 surveys (in which uniform methods of 
reporting were employed) the median cost of CAM-use per patient 
per month was £20.5 (SD=83.8) [13-18]. Predictors of CAM-use were 
mentioned in 11 (50%) surveys [6,11-19,25]. In the majority of those 
surveys, being young, highly educated and female were predictors of 
CAM-use. Across surveys on herbal medicines, the median prevalence 
rate was 51.6 (SD=9.4). 
Table 2 summarizes the prevalence rates according to sample size, 
response rate and survey design. The median prevalence rates did not 
differ significantly according to response rates. In surveys with sample 
size of >500, the median prevalence rate was 31.5 which was lower than 
Sample size (N) Median prevalence rate since cancer diagnosis 
(SD)
0-100 32.7 (7.8)
(n=3)
101-500 38.2 (13.2)
(n=2)
501- 31.5 (0.0)
(n=1)
Response rate (%)
50-70 30.8 (2.6)
(n=2)
71- 31.5 (0.0)
(n=1)
Survey design
Postal surveys 31.5 (1.9)
(n=3)
Interviews 47.6 (0.0)
(n=1)
Table 2: The average prevalence rates as a function of sample size, response rate 
and survey design.
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Figure 2: Prevalence of CAM-use over time (based on surveys on CAM in 
general, since the diagnosis of cancer).
CAM modality Conclusions regarding effectiveness available at: http://www.cam-cancer.org
I. Herbal medicine 
Aloe vera “Aloe vera gel is applied topically and is used for radiation-induced skin problems. However, clinical trials show that it is inef-
fective for that purpose. Aloe vera latex (juice) is taken orally. It has been insufficiently tested as a cancer therapy.”
Black cohosh (Actaea racemosa) “Evidence from three randomised clinical trials is not sufficient to support the use of black cohosh extracts for treatment of hot 
flushes in breast cancer patients undergoing chemotherapy or receiving tamoxifen.”
Boswellia spp “No firm conclusions can be drawn on the effect of orally administered Boswellia extracts on peritumoural brain oedema, brain 
tumours, brain metastases or any other cancer in women, men or children.”
Cannabinoids “The antiemetic efficacy of cannabinoids in comparison to placebo in chemotherapy-induced nausea/vomiting has been estab-
lished in a systematic review. The use of cannabinoids for anorexia-cachexia-syndrome in advanced cancer is not supported 
by the evidence from randomised controlled trials. Several randomised controlled trials indicate a mild analgesic effect of 
cannabinoids in cancer patients.”
Echinacea spp “Several potential uses of echinacea in cancer management have been investigated but there is currently insufficient robust 
evidence to support these.”
Garlic (Allium sativum) “Garlic is said to reduce the risk of certain cancers.The evidence for this assumption is encouraging but not strong.”
Green tea (Camellia Sinensis) “The evidence for an association between green tea consumption and the incidence of cancer is generally inconsistent.”
Milk vetch (Astragalus mongolicus) “Data from clinical trials are of low quality and need to be confirmed.”
Mistletoe (Viscum album) “Numerous in-vitro data suggest anti-cancer activity. Non-randomised trials suggest effectiveness. The results of rigorous 
RCTs are, however, less convincing.”
Panax ginseng and Panax quinquefolius “There is preliminary evidence from two pilot studies to support the use of both ginseng-species for cancer-related fatigue. 
P.ginseng and P. quinquefolius appear to be relatively safe when used as mono-substance and within the recommended dos-
age.”
St. John’s wort(Hypericum perforatum) “Some people also promote it as a cancer drug but there is no good evidence to support this claim. St. John’s wort may 
reduce the blood levels of many conventional drugs, including some cancer medicines.”
Sweet wormwood (Artemisia annua) “There is currently insufficient scientific evidence in humans to support the use of Artemisia in cancer patients.”
II.Homeopathy “The evidence for homeopathy in oncology is not convincing”
III. Aromatherapy “Weak evidence is available that aromatherapy can reduce anxiety, depression, sleep problems and improve a patient’s gen-
eral wellbeing. No evidence is available for long term effects of aromatherapy (over 2 weeks).”
IV. Reflexology “There is insufficient objective evidence to suggest that reflexology provides valuable support for people with cancer.” 
V. Relaxation 
Progressive muscle relaxation “There is insufficient evidence for the effectiveness of PMR for cancer patients suffering from pain, anxiety, depression, sleep 
disorders and chemotherapy-induced nausea.”
Autogenic training “Based on one clinical trial and two pilot studies, it is not possible to draw conclusions about the effectiveness of autogenic 
therapy for people with cancer.”
Table 3: The evidence for the 5 most popular forms of CAM.
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in surveys with sample size >100 and <500 (median of 38.2; SD=13.2). 
In the survey with the lowest sample size the prevalence of CAM-use 
was 22.7% [18]. In the survey with the highest sample size this estimate 
was 31.5% [19]. In postal surveys, the median prevalence rates were 
much lower than those that emerged from interviews. There was no 
clear trend in the use of CAM over time (Figure 2). 
Herbal medicine was ranked as the most popular type of CAM in 
9 (2 in 1; as 3 in 2; as 4 in 0; as 5 in 0) surveys, homeopathy in 3 (2 in 
2; as 3 in 0; as 4 in 0; as 5 in 0) surveys, aromatherapy in 3 (2 in 1; as 3 
in 1; as 4 in 1; as 5 in 0) surveys, reflexology in 2 (2 in 1; as 3 in 1; as 4 
in 0; as 5 in 0) surveys and relaxation in 1 (2 in 1; as 3 in 0; as 4 in 1; as 
5 in 0) surveys (based on CAM in general surveys). Using our ranking 
method, herbal medicine was the most popular form of CAM (in 40.9% 
of surveys), followed by homeopathy (13.6% of surveys) and aroma-
therapy (13.6%), reflexology (9%) and relaxation (4.5%). The median 
percentage values of the 5 most popular CAM modalities are as follows: 
herbal medicine (30.0; SD=14.9), homeopathy (13.0; SD=11.1), aro-
matherapy (19; SD=20.9), reflexology (22.5; SD=17.6) and relaxation 
(25.7; 0.0). Reiki was also ranged as the most popular form of CAM in 
4.5% of all surveys. 
Discussion 
Our review was aimed at summarizing and critically evaluating the 
evidence from surveys of CAM-use by UK cancer patients published in 
the past decade. Our findings suggest that, on average, almost a third of 
UK cancer patients used CAM since their cancer diagnosis. This figure 
is similar to the one found globally for any cancer [29] and for prostate 
cancer [30]. To the best of our knowledge, this is the first systematic 
review of surveys solely focusing on UK cancer patients. Our analyses 
suggest that the 5 most popular forms of CAM in the UK are: herbal 
medicine, homeopathy, aromatherapy, reflexology and relaxation.
This begs the question whether any of these treatments demonstra-
bly generate more good than harm. In order to answer it, it is helpful 
to differentiate between CAM-use for curing a cancer and CAM-use 
for supportive or palliative cancer. None of the CAM treatments are 
effective cancer cures [31]. Their use for this purpose should therefore 
be discouraged [32]. 
The use of CAM for supportive or palliative care is a more complex 
issue [33]. The evidence for the 5 most popular forms of CAM is briefly 
summarized in Table 4. It shows that the evidence is mixed but mostly 
not positive. Where encouraging results exist, the evidence is usually 
not entirely convincing. Moreover, one should acknowledge the fact 
that none of these treatments are devoid of risks [1]. It follows that, 
even for supportive and palliative cancer care, we should not uncriti-
cally recommend all forms of CAM to our patients. 
Our review has several limitations that should be kept in mind 
when interpreting its results. Firstly, even though our searches were 
extensive, we cannot be entirely sure that all relevant articles were lo-
cated. Secondly, since there is no gold-standard assessment tool for 
surveys [34] formal quality assessment was neither planned nor per-
formed. We noticed, however, that most surveys had reasonably high 
response rates or used validated outcome measures. Thirdly, we only 
calculated the prevalence rates since/after the diagnosis of cancer [30] 
and omitted e.g. 12 month or lifetime ones. Fourthly, a formal meta-
analysis was deemed implausible due to significant heterogeneity of 
the primary data. Finally, one survey did not provide with sub-group 
analyses [16] which prevented us from accurately calculating the total 
sample size across all surveys. 
In conclusion, large proportions of UK cancer patients use CAM, 
and herbal remedies are particularly popular. Oncologists should 
therefore be aware of the both harms and the benefits, the use of CAM 
may entail. 
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